Location: Palo Alto, CA
CIK: 0001664974 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $58.51M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EVLV | Evolv Technologies Holdings, Inc. | 4,590,000 | $32.86M | 56.2% | $5.61 | +26.7% | COM CL A | 30049H102 |
| RXRX | Recursion Pharmaceuticals, Inc. | 5,941,120 | $24.3M | 41.5% | $18.82 | -73.7% | CL A | 75629V104 |
| — | Mind Medicine (MindMed) Inc. | 100,350 | $1.344M | 2.3% | $3.17 | — | COM NEW | 60255C885 |